Signaling pathways
-
BA5571 VU6012962Summary: VU6012962 is an orally bioavailable, CNS-permeable, metabotropic glutamate receptor 7-negative modifier of mutations (NAM). -
BA5572 AZD-8529Summary: AZD-8529 is an effective. -
BA5573 DecoglurantSummary: Decoglurant (RO4995819) is a negative variational modulator. -
BA5574 LY487379Summary: LY487379 is a selective human orthomolecular modulator (PAM). -
BA5575 ABP688Summary: ABP688 is a high affinity antagonist. -
BA5576 Methoxy-PEPySummary: Methoxy-PEPy is a highly potent and selective inhibitor of the mGlu5 receptor. -
BA5577 HTL14242Summary: HTL14242 (HTL0014242) is an advanced, orally active negatively variable modulator with summed values of 9.3 and 9.2, respectively. -
BA5578 FPTQSummary: FPTQ is a potent antagonist with inhibitory values of 6 nM and 1.4 nM in human and mouse, respectively. -
BA5579 JNJ-46281222Summary: JNJ-46281222 is a selective metabolic glutamate 2 efficient PAM (orthosteric modifier). -
BA5580 FTIDCSummary: FTIDC is an oral, non-competitive, selective metabotropic glutamate receptor 1 antagonist.

